Abstract
Omeprazole, a substituted benzimidazole, and a potent inhibitor of gastric parietal cell H+/K+ ATPase, was tested for drug interactions at two dose levels (30 mg and 60 mg/day) in man using the model drugs [14C]-aminopyrine and antipyrine. Elimination of both models was assessed before and after 15 days treatment with omeprazole. In addition [14C]-aminopyrine metabolism was assessed on day 2 of treatment to investigate the rapidity of onset of any effect. In 10 healthy male volunteers omeprazole 60 mg/day for 14 days prolonged aminopyrine 14CO2 half life (t1/2), measured on the 15th day, by 21% (P less than 0.05), and reduced percent dose demethylated in 2 h (ABT2) by 19% (P less than 0.005). No effect was seen on day 2 of therapy. After 14 days treatment antipyrine half-life was prolonged by 10% (P less than 0.025) and clearance was reduced by 14% (P = 0.063). In nine healthy male volunteers omeprazole 30 mg/day for 14 days prolonged aminopyrine 14CO2 by 13% and reduced ABT2 by 11%. Both changes just failed to reach statistical significance. At this dose antipyrine metabolism was unaltered. As the dose of omeprazole used in clinical practice may be less than 30 mg/day it is unlikely that metabolic inhibition will occur during routine use, although it will be necessary to test for interactions with therapeutically more important compounds. Interactions should be looked for when large doses of omeprazole are being used to treat hypersecretory states.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dickins M., Bridges J. W. The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P-450 and the inhibition of monooxygenation. Biochem Pharmacol. 1982 Apr 1;31(7):1315–1320. doi: 10.1016/0006-2952(82)90022-3. [DOI] [PubMed] [Google Scholar]
- Fellenius E., Berglindh T., Sachs G., Olbe L., Elander B., Sjöstrand S. E., Wallmark B. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Nature. 1981 Mar 12;290(5802):159–161. doi: 10.1038/290159a0. [DOI] [PubMed] [Google Scholar]
- Gustavsson S., Adami H. O., Löf L., Nyberg A., Nyrén O. Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet. 1983 Jul 16;2(8342):124–125. doi: 10.1016/s0140-6736(83)90114-9. [DOI] [PubMed] [Google Scholar]
- Henry D. A., Macdonald I. A., Kitchingman G., Bell G. D., Langman M. J. Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J. 1980 Sep 20;281(6243):775–777. doi: 10.1136/bmj.281.6243.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henry D. A., Sharpe G., Chaplain S., Cartwright S., Kitchingman G., Bell G. D., Langman M. J. The [14C]-aminopyrine breath test. A comparison of different forms of analysis. Br J Clin Pharmacol. 1979 Dec;8(6):539–545. doi: 10.1111/j.1365-2125.1979.tb01041.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jack D., Mitchard M., Smith R. N. Influence of ranitidine on plasma metoprolol concentrations. Br Med J (Clin Res Ed) 1983 Jun 25;286(6383):2064–2064. doi: 10.1136/bmj.286.6383.2064-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Müller-Lissner S. A., Sonnenberg A., Blum A. L. Does gastric aminopyrine clearance reflect gastric mucosal blood flow or parietal cell function? Gut. 1981 Dec;22(12):997–1002. doi: 10.1136/gut.22.12.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Puurunen J., Sotaniemi E., Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol. 1980 Aug;18(2):185–187. doi: 10.1007/BF00561588. [DOI] [PubMed] [Google Scholar]
- Serlin M. J., Sibeon R. G., Breckenridge A. M. Lack of effect of ranitidine on warfarin action. Br J Clin Pharmacol. 1981 Dec;12(6):791–794. doi: 10.1111/j.1365-2125.1981.tb01308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spahn H., Mutschler E., Kirch W., Hoensch H., Ohnhaus E. E., Janisch H. D. Influence of ranitidine on plasma metoprolol concentrations. Br Med J (Clin Res Ed) 1983 Sep 17;287(6395):838–838. doi: 10.1136/bmj.287.6395.838-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walt R. P., Gomes M. D., Wood E. C., Logan L. H., Pounder R. E. Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) 1983 Jul 2;287(6384):12–14. doi: 10.1136/bmj.287.6384.12. [DOI] [PMC free article] [PubMed] [Google Scholar]